Binge Senpai

CompletedAnime

Luv Wave

ラヴ ウェーブ

“Elite agent and robot assistant face undead target, global virus, and mysterious drug in high-stakes mission.”

3 episodes27 min

Action, Drama, Horror, Mystery, Sci-Fi, Hentai, DetectiveWinter 2000Triple XRx - Hentai

5.9 Community score

4,051 viewers6 favorites

Luv Wave

For you

Add Luv Wave to your library

Episodes · 3

3/3 aired

EP 01 EP 03

For you

AI-powered analysis tailored to your taste

Would you love or hate this?

Sign up to unlock
  • Personalized to you
  • Honest pros & cons
  • Based on your library

Synopsis

Elite agent and robot assistant face undead target, global virus, and mysterious drug in high-stakes mission.

Takikawa Kanako, a secret agent that specialize in information and assassination. He has a robot girl for assistant. So far, they have 100% success rate, but their new target doesn't seem to want to stay dead. While finding out what's going on, they have to deal with a world network stopping virus and a strange new drug. Can he remember and how much does she love him? (Source: AnimeNfo)

What people say

Community consensus

Derived from 2 sampled reviews

6.5/10

What 2 viewers settled on. 100% recommend

Score distribution

median 6.5mode 6σ 0.50

Agreement

Tight

Strong agreement

σ 0.50 · scores cluster tight


The polarity gap

Not enough recommend signal yet

Score over time

0.50

Running avgNov 2010 Aug 2017

Verbosity

Short · 0% Medium · 100% Long · 0%

In one paragraph

Auto-summarised

Watch order & related

A self-contained story.

No sequels, spin-offs or alternate tellings — Luv Wave begins and ends here.

Trailers & videos

See all

If you stay for this, you'll stay for these

See all

The community pairs this with

See all

Production slate

Reel · 01 Cat. №BS-2902

A Ova Production · Winter 2000

Triple X.

in association with Pink Pineapple · Discovery

Format
3 × 27′
eps × min
Total runtime
1h 21m
all episodes
Aired
Mar 2000 – Oct 2000
Winter 2000
Source
Ova
media type
Rated
Rx
Hentai
Ref.
BS-2902
catalog

In the news

See all